REVELATION. The Moroccan pharmaceutical group Laprophan finalized, on June 17, the acquisition of a majority stake in Rivopharm, a Swiss company specializing in specialty medicines and high value-added pharmaceutical solutions. Dr Farid Bennis describes it as a “historic first: the Moroccan drug is recognized internationally and in Switzerland, a country of the global pharmaceutical industry”. The post Laprophan finalizes its first acquisition in Europe and takes control of the Swiss Rivopharm appeared first on Médias24 - Number one in Moroccan economic information.